Medical and Diagnostic Laboratory Services Market Report 2026

The medical and diagnostic laboratory services market size has grown strongly in recent years. It will grow from $212.41 billion in 2025 to $229.3 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to growth in disease burden, increasing physician reliance on diagnostics, expansion of hospital infrastructure, rising healthcare awareness, improved access to basic diagnostic testing.

The medical and diagnostic laboratory services market size is expected to see strong growth in the next few years. It will grow to $314.61 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing chronic disease prevalence, rising demand for personalized diagnostics, growth of preventive healthcare programs, expansion of diagnostic services in tier 2 and tier 3 cities, increasing public and private healthcare spending. Major trends in the forecast period include rising demand for preventive and early disease diagnostics, growing shift toward outsourced diagnostic services, expansion of integrated diagnostic imaging and lab networks, increasing adoption of home sample collection services, rising focus on quality standards and accreditation compliance.

The rise in sedentary occupations, hectic lifestyles, and evolving consumer habits is influencing the disease patterns of the global population, particularly non-communicable diseases such as cancer, diabetes, and cardiovascular disorders. Extended working hours, reduced physical activity, and poor dietary and drinking habits are significant contributors to chronic conditions like diabetes. For example, in July 2023, the Office for National Statistics, a UK-based agency, reported that in the first quarter of 2023, over 1.35 million individuals (53%) who were inactive due to long-term illness experienced depression, anxiety, or nervousness. Diagnostic tests for these conditions include HbA1c tests for diabetes monitoring, biopsies, tumor marker tests, bone scans, MRI and CT scans for various cancers, electrocardiograms, chest X-rays, cardiac CT scans, and stress tests for detecting cardiovascular diseases. The growing prevalence of lifestyle-related diseases is expected to increase the demand for diagnostic tests for these conditions, thereby driving the medical and diagnostic laboratory services market during the forecast period.

The growing geriatric population is anticipated to drive the expansion of the medical and diagnostic laboratory services market in the coming years. The geriatric population refers to older adults, generally defined as individuals aged 65 and above. Medical and diagnostic laboratory services for this population are crucial for early disease detection and monitoring, enabling timely interventions and enhancing overall health outcomes in elderly individuals. For example, in July 2024, the UK Parliament's House of Commons Library, a UK-based government body, reported that in 2022, there were 12.7 million people aged 65 or older in the UK, accounting for 19% of the total population. By 2072, this number is projected to rise to 22.1 million, representing 27% of the population. Consequently, the increasing geriatric population is fueling the growth of the medical and diagnostic laboratory services market.

Major companies operating in the medical and diagnostic laboratory services market are concentrating on developing innovative solutions, such as enterprise molecular-diagnostics workflow software, to address the increasing demand for faster, higher-throughput qPCR testing, enhanced assay standardization, regulatory traceability, and improved laboratory efficiency driven by public-health monitoring and expanding molecular test menus. Enterprise molecular-diagnostics workflow software is a unified, on-premise/integrated platform that connects instruments, assays, sample and reagent tracking, automated quality-control and data interpretation, and laboratory information systems (LIS) within a single interface. For example, in July 2023, Thermo Fisher Scientific, a US-based life-sciences company, introduced Diomni Enterprise Software, an enterprise qPCR/molecular diagnostics workflow platform. Diomni is designed as a scalable, on-premise software suite that links sample tracking, instrument control, and result reporting into a single ecosystem; it supports assay development files (ADF) and routine qPCR workflows, automates QC and fluorescence-curve interpretation, and integrates with LIS for audit trails and 21 CFR Part 11-style controls. Distinct features include customizable, lockable assay templates, concurrent multi-user access, automated reagent and sample traceability, and built-in compliance/audit functionality - benefits that result in fewer manual steps, improved reproducibility, and reductions in qPCR time-to-results of several hours, as reported by early adopters.

Major companies operating in the medical and diagnostic laboratory services market are Laboratory Corporation of America, Eurofins Scientific, Quest Diagnostics Incorporated, Sonic Healthcare Limited, RadNet, OPKO Health, Myriad Genetics, Charles River Laboratories Inc., NeoGenomics Laboratories Inc., Bio-Reference Laboratories Inc., Guardant Health Inc., Invitae Corporation, Natera Inc., Foundation Medicine Inc., Veracyte Inc., Exact Sciences Corporation, Fulgent Genetics Inc., Progenity Inc., Adaptive Biotechnologies Corporation, Biocept Inc., Interpace Biosciences Inc., Psychemedics Corporation, Aeon Global Health Corp., Avellino Labs USA Inc., Bio-Techne Corporation, Enzo Clinical Labs Inc., Genoptix Inc., Genova Diagnostics Inc.

North America was the largest region in the medical and diagnostic laboratory services market in 2025. Asia-Pacific was the second largest region in the medical and diagnostic laboratory services market. The regions covered in the medical and diagnostic laboratory services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical and diagnostic laboratory services market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

Tariffs affect the medical and diagnostic laboratory services market by increasing the cost of imported diagnostic equipment, reagents, and imaging devices. Laboratories in regions heavily dependent on imported analyzers and consumables, particularly in asia-pacific and latin america, may face higher operational expenses. These cost pressures can impact test pricing and expansion plans. However, tariffs also encourage local manufacturing of diagnostic kits and equipment, supporting long-term cost control and supply resilience.

The medical and diagnostic laboratory services market research report is one of a series of new reports that provides medical and diagnostic laboratory services market statistics, including medical and diagnostic laboratory services industry global market size, regional shares, competitors with a medical and diagnostic laboratory services market share, detailed medical and diagnostic laboratory services market segments, market trends and opportunities, and any further data you may need to thrive in the medical and diagnostic laboratory services industry. This medical and diagnostic laboratory services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical and diagnostic laboratory services provide tests to diagnose various diseases. These tests help determine whether an individual has been affected by a particular disease. Such services enable the delivery of timely, cost-effective, and high-quality diagnostic care in safe environments.

The primary types of medical and diagnostic laboratory services include diagnostic imaging centers and medical laboratory services. A diagnostic imaging center offers technical or comprehensive diagnostic imaging solutions. Expenditures in this sector can be categorized as public or private and are applied across areas such as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and more. These services are utilized by both males and females.

The medical and diagnostic laboratory services market includes revenues earned by entities by providing diagnostic services such as diagnostic laboratory services, X-ray, CT scan, and Mammography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.